Lupin 2024

PBMs

NCPA urges review of anticompetitive PBM conduct

NCPA urges review of anticompetitive PBM conduct

ALEXANDRIA, Va. — As part of what the Federal Trade Commission said will be the first in a series of monthly meetings opening its work to the public, National Community Pharmacists Association General Counsel Matthew Seiler, RN, Esq., spoke to the commission at today’s open meeting about pharmacy benefit managers and their anticompetitive practices harming patients and

NCPA praises NAIC plan to develop PBM white paper

NCPA praises NAIC plan to develop PBM white paper

ALEXANDRIA, Va. — On Tuesday, the National Association of Insurance Commissioners’ Health Insurance and Managed Care (B) Committee approved a charge for its Pharmacy Benefit Manager Regulatory Issues (B) Subgroup to develop a white paper addressing PBMs’ role in the prescription drug supply chain and examining state provisions addressing various PBM practices. Additionally, the subgroup

PBMs: The only entity reducing Rx costs on behalf of patients

PBMs: The only entity reducing Rx costs on behalf of patients

WASHINGTON — Pharmaceutical Care Management Association president and CEO JC Scott issued the following statement on today’s hearing in the House Committee on Oversight and Reform on pricing practices for prescription drugs: “We appreciate the House Oversight Committee keeping a spotlight on drug manufacturers’ pricing practices. While drug manufacturers are solely responsible for setting and

New research: PBMs save $962 per person annually

New research: PBMs save $962 per person annually

WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices

Rx groups unite to fight PBMs

Rx groups unite to fight PBMs

ALEXANDRIA, Va.  – The National Community Pharmacists Association (NCPA) and the Arkansas Pharmacists Association (APA), along with the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA), announced today they will file an amicus curiae brief with the Supreme Court of the United States in support of a case that pits

NCPA endorses bill to ban PBM spread pricing tactic

NCPA endorses bill to ban PBM spread pricing tactic

ALEXANDRIA, Va. — The National Community Pharmacists Association is endorsing H.R. 5281, the Drug Price Transparency in Medicaid Act, which would ban the use of spread pricing by pharmacy benefit managers in Medicaid managed care. Currently, PBMs can overbill Medicaid managed care programs, under-reimburse pharmacies for medications dispensed, and retain the difference, which is referred to as

Independent pharmacies suffer from DIR fees; PBM champions for change

Independent pharmacies suffer from DIR fees; PBM champions for change

GAINESVILLE, Ga. – As more independent pharmacies close or file for bankruptcy across the U.S., industry experts are looking for ways to improve, standardize and make transparent DIR fee calculations as a means to boost pharmacy solvency, particularly in urban and small rural towns, which are being hit the hardest by closures. “It is simply not a

Capital Rx working to lower prescription drug costs 

Capital Rx working to lower prescription drug costs 

NEW YORK — Capital Rx, a next generation pharmacy benefits manager, announced on Wednesday the launch of its Clearinghouse Model, the first major innovation in the way prescriptions are priced for over three decades. Through this new pricing framework, Capital Rx brings full visibility to drug unit prices and eliminates arbitrary price variability for patients

NCPA urges PBM reform in major media print ads

NCPA urges PBM reform in major media print ads

ALEXANDRIA, Va. — In print ads Tuesday in the Washington Post and the Wall Street Journal, the National Community Pharmacists Association is urging policymakers to rein in pharmacy benefit managers to help lower drug costs. These ads complement NCPA’s ongoing efforts in its years-long campaign to reform pharmacy direct and indirect remuneration (DIR) fees, a

PBMs support transparency for consumers, health plan sponsors, policymakers

PBMs support transparency for consumers, health plan sponsors, policymakers

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-time benefit tools to give prescribers and patients at the point of prescribing information on

PBMs support increased transparency in prescription drug supply chain

PBMs support increased transparency in prescription drug supply chain

WASHINGTON — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug prices, the Pharmaceutical Care Management Association (PCMA) is confirming its principles on transparency in the prescription drug supply chain. PCMA commends the Subcommittee’s work to bring more transparency to drug prices. America’s pharmacy benefit managers (PBMs) support greater

Moriarty addresses prescription drug affordability at Roll Call Live

Moriarty addresses prescription drug affordability at Roll Call Live

  WASHINGTON — In the midst of a very important discussion around prescription drug pricing in Washington, D.C., CVS Health sponsored an event earlier this week with CQ Roll Call titled “Empowering Patients as Partners in Health Care” to focus on the issue and the consumer experience in health care. At the event, policymakers and

Transparent pharmacy benefits needed

Transparent pharmacy benefits needed

NEW YORK — Now more than ever, the media landscape is turning an increasingly critical eye towards pharmacy benefit managers — the health care system’s favorite scapegoats. As health care costs continue to rise at staggering rates, these organizations can help their clients save on drug costs. However, it’s a complicated and confusing minefield in

Higher script volumes aid in Q1 gains for CVS

Higher script volumes aid in Q1 gains for CVS

WOONSOCKET, R.I. — CVS Health’s revenue was on the rise as it filled more prescriptions and benefited from a lower effective tax rate, the company said today in reporting its operating results for the three months ended March 31. The drug store chain said its first quarter revenue increased 2.6% to $45.7 billion from $44.5

PP_1170x120_10-25-21